Jack Van Ko, MD | |
1001 S George St, York, PA 17403-3676 | |
(717) 851-2450 | |
(717) 851-3469 |
Full Name | Jack Van Ko |
---|---|
Gender | Male |
Speciality | Emergency Medicine |
Experience | 28 Years |
Location | 1001 S George St, York, Pennsylvania |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1023143674 | NPI | - | NPPES |
Facility Name | Location | Facility Type |
---|---|---|
York Hospital | York, PA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
York Hospital | 2961307467 | 84 |
News Archive
More than 2.6 billion people - over 40 per cent of the world's population - do not have access to basic sanitation, and more than one billion people still use unsafe sources of drinking water, warns a report released today by the World Health Organization and UNICEF.
In one of the first reported cases of its kind, a 3-week-old infant in critical condition recovered from COVID-19 due to rapid recognition and treatment by physicians from McGovern Medical School at The University of Texas Health Science Center at Houston/
Results of a nationwide telephone survey have shown that the rate of peanut allergies in children more than tripled from 1997 to 2008. The data are reported in the May 12 issue of the Journal of Allergy and Clinical Immunology.
The Janssen Pharmaceutical Companies of Johnson & Johnson announced today new data that showed a vast majority of patients with moderate to severe plaque psoriasis receiving TREMFYA (guselkumab), who achieved at least a 90 percent improvement in the Psoriasis Area and Severity Index (PASI 90) at week 28, maintained a PASI 90 response with continuous treatment through week 72.
› Verified 2 days ago
Entity Name | York Hospital |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1326060492 PECOS PAC ID: 2961307467 Enrollment ID: O20031205000629 |
News Archive
More than 2.6 billion people - over 40 per cent of the world's population - do not have access to basic sanitation, and more than one billion people still use unsafe sources of drinking water, warns a report released today by the World Health Organization and UNICEF.
In one of the first reported cases of its kind, a 3-week-old infant in critical condition recovered from COVID-19 due to rapid recognition and treatment by physicians from McGovern Medical School at The University of Texas Health Science Center at Houston/
Results of a nationwide telephone survey have shown that the rate of peanut allergies in children more than tripled from 1997 to 2008. The data are reported in the May 12 issue of the Journal of Allergy and Clinical Immunology.
The Janssen Pharmaceutical Companies of Johnson & Johnson announced today new data that showed a vast majority of patients with moderate to severe plaque psoriasis receiving TREMFYA (guselkumab), who achieved at least a 90 percent improvement in the Psoriasis Area and Severity Index (PASI 90) at week 28, maintained a PASI 90 response with continuous treatment through week 72.
› Verified 2 days ago
Mailing Address | Practice Location Address |
---|---|
Jack Van Ko, MD 3421 Concord Rd, York, PA 17402-9001 Ph: (717) 851-1405 | Jack Van Ko, MD 1001 S George St, York, PA 17403-3676 Ph: (717) 851-2450 |
News Archive
More than 2.6 billion people - over 40 per cent of the world's population - do not have access to basic sanitation, and more than one billion people still use unsafe sources of drinking water, warns a report released today by the World Health Organization and UNICEF.
In one of the first reported cases of its kind, a 3-week-old infant in critical condition recovered from COVID-19 due to rapid recognition and treatment by physicians from McGovern Medical School at The University of Texas Health Science Center at Houston/
Results of a nationwide telephone survey have shown that the rate of peanut allergies in children more than tripled from 1997 to 2008. The data are reported in the May 12 issue of the Journal of Allergy and Clinical Immunology.
The Janssen Pharmaceutical Companies of Johnson & Johnson announced today new data that showed a vast majority of patients with moderate to severe plaque psoriasis receiving TREMFYA (guselkumab), who achieved at least a 90 percent improvement in the Psoriasis Area and Severity Index (PASI 90) at week 28, maintained a PASI 90 response with continuous treatment through week 72.
› Verified 2 days ago
Brian David Holsinger, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1001 S George St, York, PA 17403 Phone: 717-851-2311 | |
Jacob Russell Mckenzie, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 1001 S George St, York, PA 17403 Phone: 717-851-2311 | |
James T. Amsterdam, D.M.D., M.D. Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 1735 Wyndham Dr, York, PA 17403 Phone: 717-854-1255 | |
Dr. Chalak N Muhammad, MD, MPH Emergency Medicine Medicare: Medicare Enrolled Practice Location: 292 Saint Charles Way, York, PA 17402 Phone: 717-851-6231 Fax: 717-741-1719 | |
Chu-en Lin, Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1001 S George St, York Hospital, York, PA 17403 Phone: 717-851-2311 | |
Samuel Lucas Creighton, D.O. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1001 S George St, York, PA 17403 Phone: 717-851-3469 |